Rankings
▼
Calendar
SRPT Q2 2023 Earnings — Sarepta Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
SRPT
Sarepta Therapeutics, Inc.
$2B
Q2 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$261M
+11.9% YoY
Gross Profit
$227M
86.9% margin
Operating Income
-$134M
-51.1% margin
Net Income
-$24M
-9.2% margin
EPS (Diluted)
$-0.27
QoQ Revenue Growth
+3.1%
Cash Flow
Operating Cash Flow
-$122M
Free Cash Flow
-$140M
Stock-Based Comp.
$47M
Balance Sheet
Total Assets
$3.1B
Total Liabilities
$2.4B
Stockholders' Equity
$741M
Cash & Equivalents
$852M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$261M
$233M
+11.9%
Gross Profit
$227M
$196M
+16.1%
Operating Income
-$134M
-$211M
+36.8%
Net Income
-$24M
-$231M
+89.7%
Geographic Segments
UNITED STATES
$204M
85%
Non-US
$35M
15%
← FY 2023
All Quarters
Q3 2023 →